Andrew A Borkowski

Prof. Andrew A Borkowski

orcid

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 1998 in Urology
Verified
Journal Article
Closed access
TMTimothy J. Mackey
Timothy J. Mackey
ABAndrew A Borkowski
Andrew A Borkowski
PAPradip Amin
Pradip Amin
SJStephen C. Jacobs
Stephen C. Jacobs
NKNatasha Kyprianou
Natasha Kyprianou

1 June 1999 in Journal of Urology
Verified
Journal Article
Closed access
JCJoanna K. Chon
Joanna K. Chon
ABAndrew A Borkowski
Andrew A Borkowski
APAlan W. Partin
Alan W. Partin
JIJohn T. Isaacs
John T. Isaacs
SJStephen C. Jacobs
Stephen C. Jacobs
NKNatasha Kyprianou
Natasha Kyprianou
Conclusions These findings demonstrated that alpha-blockers as a class may regulate prostate growth by inducing apoptosis in both the epithelial and stromal cells, with little effect on cell proliferation. Apoptosis-mediated prostate stromal regression appears as a molecular mechanism underlying the therapeutic response to alpha 1 blockade in the treatment of BPH.

1 February 2001
Verified
Journal Article
Closed access
RWR N Winter
R N Winter
AKA Kramer
A Kramer
ABAndrew A Borkowski
Andrew A Borkowski
NKN Kyprianou
N Kyprianou

1 October 1999 in The American Journal of Pathology
Verified
Journal Article
Closed access
JPJoseph J. Del Pizzo
Joseph J. Del Pizzo
ABAndrew A Borkowski
Andrew A Borkowski
SJStephen C. Jacobs
Stephen C. Jacobs
NKNatasha Kyprianou
Natasha Kyprianou

23 April 2004 in International Journal of Cancer
Verified
Journal Article
Open access
PDF file
MKMartha C. Kimos
Martha C. Kimos
SWSuna Wang
Suna Wang
ABAndrew A Borkowski
Andrew A Borkowski
GYGuang‐Yu Yang
Guang‐Yu Yang
CYChung S. Yang
Chung S. Yang
SMStephen J. Meltzer
Stephen J. Meltzer
PCNA and esophagin have been implicated in the multistep process of carcinogenesis, but simultaneous characterization of these proteins in the early stages of esophageal neoplastic progression has yet to be undertaken. In morphologically normal esophageal epithelium, esophagin stains the granular layer cells, principally in their cell membrane portions. PCNA, in contrast, stains the nuclei of cells in the parabasal and basal layers. We examined 201 regions from 47 patients that represented different stages of esophageal neoplasia, comprising 34 areas of normal mucosa, 18 of dysplasia in squamous epithelium (DYS/SC), 39 squamous cell carcinoma (SCCA), 29 areas of Barrett's esophagus, 48 of Barrett's dysplasia (DYS/BAR) and 33 areas of adenocarcinoma (AC). The immunostaining patterns of esophagin and PCNA were evaluated and graded for level of expression. There was loss of esophagin expression in the high‐ and low‐grade dysplasias compared to normal epithelia. In the squamous dysplasias, there was more intense staining (of esophagin) in the atypical nuclei and superficial squamous epithelial cells than in the basal cells. PCNA staining was increased in intensity in the high‐grade dysplasias relative to normal basal layer cells. Combined analysis of esophagin and PCNA appears to reveal an inverse relationship between proliferation and differentiation during esophageal neoplastic progression. Moreover, this combined staining approach also offers promise for detecting esophageal cancer in early, precancerous stages.

10 November 2021 in Federal Practitioner
Verified
Journal Article
Closed access
BTBrannon Thomas
Brannon Thomas
ABAndrew A Borkowski
Andrew A Borkowski
Background: The role of artificial intelligence (AI) in health care is expanding rapidly. Currently, there are at least 29 US Food and Drug Administration-appro